World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
39910
World Ranking
8238
National Ranking
4270

John R. Teerlink publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John R. Teerlink sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 511 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John R. Teerlink D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John R. Teerlink sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John R. Teerlink is affiliated with the University of California, San Francisco in the United States. The primary field of study for their research is Medicine, with a focus on cardiology and cardiovascular medicine. Subfields contributing to their work include endocrinology, diabetes and metabolism, surgery, pulmonary and respiratory medicine, and economics and econometrics.

Their research centers on several main topics, including heart failure treatment and management, cardiovascular function and risk factors, cardiac pacing and defibrillation studies, diabetes treatment and management, mechanical circulatory support devices, and health systems, economic evaluations, and quality of life. Potassium and related disorders also form a part of their research interests.

Frequent coauthors working alongside John R. Teerlink include:

  • G. Michael Felker
  • Marco Metra
  • Adriaan A. Voors
  • John J.V. McMurray
  • Gerasimos Filippatos

Some of the publication venues where John R. Teerlink has frequently contributed are:

  • European Journal of Heart Failure
  • JACC Heart Failure
  • Journal of Cardiac Failure
  • Journal of the American College of Cardiology
  • Circulation

Selected recent papers authored or coauthored by John R. Teerlink include:

  • "Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure" (2021, European Journal of Heart Failure)
  • "The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial" (2022, Nature Medicine)
  • "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure" (2020, New England Journal of Medicine)
  • "Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America" (2023, Journal of Cardiac Failure)
  • "Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction" (2020, Circulation)

Best Publications

  • HFSA 2010 Comprehensive Heart Failure Practice Guideline.

    Lindenfeld J;Albert Nm;Boehmer Jp

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

    Maria Rosa Costanzo;Maya E. Guglin;Mitchell T. Saltzberg;Mariell L. Jessup

  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

    John R Teerlink;Gad Cotter;Beth A Davison;G Michael Felker

  • Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

    Biykem Bozkurt;Andrew J.S. Coats;Hiroyuki Tsutsui;Ca Magdy Abdelhamid

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    Milton Packer;John J. V. McMurray;Akshay S. Desai;Jianjian Gong

  • Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

    Shunichi Homma;John L.P. Thompson;Patrick M. Pullicino;Bruce Levin

  • Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

    Biykem Bozkurt;Andrew Js Coats;Hiroyuki Tsutsui;Magdy Abdelhamid

  • Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

    Barry M. Massie;Christopher M. O'Connor;Marco Metra;Piotr Ponikowski

  • Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    John R. Teerlink;Rafael Diaz;G. Michael Felker;John J.V. McMurray

  • Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With Outcomes

    Marco Metra;Gad Cotter;Beth A. Davison;G. Michael Felker

  • Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study

    John R Teerlink;Marco Metra;G Michael Felker;Piotr Ponikowski

  • Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

    Milton Packer;Wilson Colucci;Lloyd Fisher;Barry M. Massie

  • Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial

    Michael R. Zile;William H. Gaasch;Inder S. Anand;Markus Haass

  • The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

    John G. F. Cleland;John R. Teerlink;Roxy Senior;Evgeny M. Nifontov

  • Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions

    Javed Butler;Gregg C. Fonarow;Michael R. Zile;Carolyn S. Lam

  • Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials

    John J V McMurray;John R. Teerlink;Gadi Cotter;Robert C. Bourge

  • Advanced (stage D) heart failure: A statement from the heart failure society of america guidelines committee

    James Chentson Fang;Gregory A. Ewald;Larry A. Allen;Javed Butler

  • Diuretic response in acute heart failure: clinical characteristics and prognostic significance

    Mattia A. E. Valente;Adriaan A. Voors;Kevin Damman;Dirk J. Van Veldhuisen

Frequent Co-Authors

Marco Metra
Marco Metra University of Brescia
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Gad Cotter
Gad Cotter Momentum Research Inc
John G.F. Cleland
John G.F. Cleland University of Glasgow
G. Michael Felker
G. Michael Felker Duke University
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Barry H. Greenberg
Barry H. Greenberg University of California, San Diego
Michael M. Givertz
Michael M. Givertz Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always follow a traditional path. Many students now explore flexible options such as online medical and healthcare degrees. These programs offer the convenience to balance studies with other commitments and can be more affordable than on-campus alternatives.

For those interested in administrative roles, medical billing and coding online courses provide practical training to enter the vital field of healthcare data management. Nursing remains a leading choice, with cheap online fnp programs and how much does online nursing school cost guides helping students find cost-effective pathways to becoming registered nurses or advanced practice providers.

For those aiming for leadership or research careers, doctoral options like the cheapest dnp programs allow students to achieve the highest nursing credentials online for less. Exploring these online degree choices can open doors to a variety of medical careers, while providing more affordability and flexibility.

Best Scientists Citing John R. Teerlink

Trending Scientists

Recently Published Articles